Translational Development Acquisition TDACW
NASDAQ TDACW
$1.60 -0.25 (-13.51%)
As of: Sep 9, 2026 · 2:59 PM EDT

Translational Development Acquisition (TDACW) Assets Average (2025 - 2026)

Translational Development Acquisition's (TDACW) quarterly Assets Average came in at $170.4 million in Q2 2026, down 3.96% on a YoY basis from $177.4 million in Q2 2025, and down 6.67% quarter-over-quarter from $182.5 million in Q1 2026.

Analysis

Translational Development Acquisition (TDACW) Assets Average (2025 - 2026) Analysis & Trends

Translational Development Acquisition (TDACW) has reported Assets Average for 2 consecutive years, with $170.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average fell 3.96% year-over-year to $170.4 million; the trailing twelve-month figure through Jun 2026 stood at $170.4 million (down 3.96% YoY), and the FY2025 full-year result was $178.3 million, up 103.82% from the prior year.
  • Assets Average eased to $170.4 million in Q2 2026 per TDACW's latest filing, from $182.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $182.5 million in Q1 2026 and bottomed at $170.4 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Evercore 11.52 Bn 9.43 Bn 975.67 Mn 4.51 Bn
2 Jefferies Financial 11.24 Bn -4.17 Bn 3.09 Bn 76.96 Bn
3 Houlihan Lokey 9.53 Bn 8.45 Bn - 4.12 Bn
4 Cluster Group Holdings 8.00 Bn 8.00 Bn - -
5 PJT Partners 6.94 Bn 6.99 Bn 481.98 Mn 1.66 Bn
6 Moelis 6.06 Bn 5.99 Bn - 1.35 Bn
7 Piper Sandler Companies 5.20 Bn 5.09 Bn - 2.23 Bn
8 Lazard 4.97 Bn 3.99 Bn - 4.30 Bn
9 BRBI BR Partners 3.44 Bn 3.32 Bn 16.77 Mn 3.55 Bn
10 Translational Development Acquisition 52.67 Mn 52.58 Mn - 170.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170.36 Mn
Mar 31, 2026 182.52 Mn
Dec 31, 2025 180.84 Mn
Sep 30, 2025 179.08 Mn
Jun 30, 2025 177.39 Mn
Mar 31, 2025 175.80 Mn